Package 68382-354-10

{"route": ["ORAL"], "spl_id": "00be046c-e051-4430-a967-3a0d4611da22", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993541", "993557"], "spl_set_id": ["8d937ca3-3351-40f1-8192-348ba0c68162"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-354-05)", "package_ndc": "68382-354-05", "marketing_start_date": "20140215"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-354-06)", "package_ndc": "68382-354-06", "marketing_start_date": "20140215"}, {"sample": false, "description": "1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-354-10)", "package_ndc": "68382-354-10", "marketing_start_date": "20140215"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-354-16)", "package_ndc": "68382-354-16", "marketing_start_date": "20140215"}], "brand_name": "bupropion", "product_id": "68382-354_00be046c-e051-4430-a967-3a0d4611da22", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "68382-354", "generic_name": "bupropion", "labeler_name": "Zydus Pharmaceuticals USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "bupropion", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA201567", "marketing_category": "ANDA", "marketing_start_date": "20140215", "listing_expiration_date": "20261231"}